Dr Mark Carnegie-Brown has joined Glide Pharma as CEO.
He brings more than 25 years of experience in the healthcare and life sciences industry to Glide – a development and device company focused on the needle-free administration of solid dose formulations.
His past experience includes five years as CEO of protein drug development company Evolutec from 2003 to 2008 and a year as CEO of contract manufacturing organisation Aenova from 2008 to 2009.
He also served as UK and Northern Europe managing director at Elsevier Health Sciences from 2009 to 2011 and managing director of Carbon Fibre Technologies International from November 2011.
“His research and commercial experience, and in particular his expertise in building successful clinical and manufacturing programmes, will prove invaluable as Glide scales up its capabilities and advances the development of its in-house programmes,” said Mark Kirby, chairman of Glide Pharma.